PPM1D p.Ser44Trp
c.131C>G · rs373862041 · VCV1049549
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1438 | likely benign |
|---|---|---|
| REVEL | 0.13 | moderately benign-leaning |
| SaProt | LLR -9.38 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 1.6 | GERP 1.3, phastCons 1 |
| Regional constraint | o/e 0.88 | unconstrained · MANE · 307 bp · p 0.13 · regional, not allelic |
| Overall | ||
| CADD | 22.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.0676% | 1,479 |
| European (non-Finnish)grpmax | 0.0483% | 2,070 |
| Remaining individualsnot grpmax-eligible | 0.0316% | 3,169 |
| Ashkenazi Jewishnot grpmax-eligible | 0.00699% | 14,313 |
| African / African-American | 0.00545% | 18,339 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PPM1D
- Protein
- p.Ser44Trp
- Coding
- c.131C>G
- MANE Select
- NM_003620
- dbSNP
- rs373862041
- Type
- single nucleotide variant
- Location
- chr17:60600545 (GRCh38)
- Gene constraint
- LOEUF 1.183 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
- Structure
- AlphaFold pLDDT 68.15 · 1 PDB
- Residue 44
- the ppm-type phosphatase domain; the 'interaction with chek1' region; the 'disordered' region
Disease context
intellectual developmental disorder with gastrointestinal difficulties and high pain threshold — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Jansen-de Vries syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Infancy
Similar variants
- PPM1D p.Cys407Ter Pathogenic/Likely pathogenic ★★ same condition
- PPM1D p.Gln404Ter Pathogenic ★★ same condition
- PPM1D p.Gln462Ter Likely pathogenic ★★ same condition
- PPM1D p.Ser421Ter Pathogenic/Likely pathogenic ★★ same condition
- PPM1D p.Trp427Ter Pathogenic ★★ same condition
- PPM1D p.Ser89Arg Uncertain significance ★★ ⚠ same condition
- PPM1D p.Ala152= Benign/Likely benign ★★ same condition
- PPM1D c.1017+10G>T Uncertain significance ★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ppm1d-p-ser44trp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown